News Website

The power of support: One‑to‑one peer support dramatically improves treatment completion among Black endometrial cancer patients, new trial shows - MSN

The power of support: One‑to‑one peer support dramatically improves treatment completion among Black endometrial cancer patients, new trial shows MSN

Published: May 9, 2026, 10:45 p.m.

Read Full Article

Diagnostic Accuracy and Concordance of Hysteroscopy for Detecting Premalignant and Malignant Endometrial Lesions: A Retrospective Study From a Tertiary Center in Mexico - Cureus

Diagnostic Accuracy and Concordance of Hysteroscopy for Detecting Premalignant and Malignant Endometrial Lesions: A Retrospective Study From a Tertiary Center in Mexico Cureus

Published: May 9, 2026, 4:19 a.m.

Read Full Article

Dual PI3K/AKT/mTOR and CDK4/6 inhibition suppresses survivin to overcome uterine dedifferentiated endometrial carcinoma - Nature

Dual PI3K/AKT/mTOR and CDK4/6 inhibition suppresses survivin to overcome uterine dedifferentiated endometrial carcinoma Nature

Published: May 8, 2026, 3:28 p.m.

Read Full Article

Arrivent Announces Ind Clearance For Novel Tetravalent Muc16/Napi2b Targeting Adc Arr-002 With Initial Focus In Ovarian And Endometrial Cancers - TradingView

Arrivent Announces Ind Clearance For Novel Tetravalent Muc16/Napi2b Targeting Adc Arr-002 With Initial Focus In Ovarian And Endometrial Cancers TradingView

Published: May 7, 2026, 12:05 p.m.

Read Full Article

FDA clears new dual-target cancer drug for ovarian, endometrial trial - Stock Titan

FDA clears new dual-target cancer drug for ovarian, endometrial trial Stock Titan

Published: May 7, 2026, 12:02 p.m.

Read Full Article

Dear Doctor: Endometrial cancer is most common North American gynecological cancer - OregonLive.com

Dear Doctor: Endometrial cancer is most common North American gynecological cancer OregonLive.com

Published: May 6, 2026, 1 p.m.

Read Full Article

Four-Year Follow-Up Outcomes in dMMR Endometrial Cancer Presented at SGO 2026 - OncLive

Four-Year Follow-Up Outcomes in dMMR Endometrial Cancer Presented at SGO 2026 OncLive

Published: May 6, 2026, 12:02 p.m.

Read Full Article

Delayed Chylothorax After Endometrial Carcinoma: A Case of Confirmed Thoracic Duct Leak Successfully Managed Conservatively - Cureus

Delayed Chylothorax After Endometrial Carcinoma: A Case of Confirmed Thoracic Duct Leak Successfully Managed Conservatively Cureus

Published: May 6, 2026, 9:16 a.m.

Read Full Article

Managing Progression After Immunotherapy in Endometrial Cancer - OncLive

Managing Progression After Immunotherapy in Endometrial Cancer OncLive

Published: May 5, 2026, 12:07 p.m.

Read Full Article

New Endometrial Targets Beyond HER2 - OncLive

New Endometrial Targets Beyond HER2 OncLive

Published: May 5, 2026, 12:06 p.m.

Read Full Article

Latest Articles

The power of support: One‑to‑one peer support dramatically improves treatment completion among Black endometrial cancer patients, new trial shows - MSN

Diagnostic Accuracy and Concordance of Hysteroscopy for Detecting Premalignant and Malignant Endometrial Lesions: A Retrospective Study From a Tertiary Center in Mexico - Cureus

Dual PI3K/AKT/mTOR and CDK4/6 inhibition suppresses survivin to overcome uterine dedifferentiated endometrial carcinoma - Nature

Arrivent Announces Ind Clearance For Novel Tetravalent Muc16/Napi2b Targeting Adc Arr-002 With Initial Focus In Ovarian And Endometrial Cancers - TradingView

FDA clears new dual-target cancer drug for ovarian, endometrial trial - Stock Titan

Dear Doctor: Endometrial cancer is most common North American gynecological cancer - OregonLive.com

Four-Year Follow-Up Outcomes in dMMR Endometrial Cancer Presented at SGO 2026 - OncLive

Delayed Chylothorax After Endometrial Carcinoma: A Case of Confirmed Thoracic Duct Leak Successfully Managed Conservatively - Cureus

Managing Progression After Immunotherapy in Endometrial Cancer - OncLive

New Endometrial Targets Beyond HER2 - OncLive

Subscribe to Our Newsletter